Abstract
I would first of all like to begin by congratulating the authors on their work1, which, with the large population analysed, has the potential to pertinently contribute to answering the question of risk of non-melanoma skin cancer (NMSC) with tetracycline use. Certain questions arise from a reading of this work, which I would request of the authors to clarify for all readers.
This article is protected by copyright. All rights reserved.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.